These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7113038)

  • 1. [Comparative evaluation of the effect of diet, pharmaco- and balneotherapy on a number of metabolic indices in obesity].
    Lukasheva MV; Mokina MN
    Vopr Kurortol Fizioter Lech Fiz Kult; 1982; (3):46-50. PubMed ID: 7113038
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of adebit on carbohydrate and insulin metabolism in childhood obesity].
    Blatniczky L; Kautzky L; Péter F
    Orv Hetil; 1986 Jun; 127(23):1381-4, 1387-8. PubMed ID: 3523380
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of metformin on glucose tolerance and insulin binding in semistarved obese women].
    Zancanaro C; Cigolini M; Bertoldi P; Mezzena G; Giacomoni P; Bosello O
    Minerva Endocrinol; 1984; 9(2):297-301. PubMed ID: 6390142
    [No Abstract]   [Full Text] [Related]  

  • 4. [The importance of the biguanides in the treatment of obesity].
    Bittnerová H; Masek J; Rath R
    Z Gesamte Inn Med; 1969 Mar; 24(5):139-42. PubMed ID: 5785830
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of a clinical study of a group of hospitalized diabetics under treatment with depot buformin].
    Durante F; Scaffidi A; Rotolo G; Rini GB
    Minerva Med; 1978 May; 69(24):1665-72. PubMed ID: 662170
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 diabetes mellitus.
    Ohara S; Komatsu R; Matsuyama T
    Diabetes Res Clin Pract; 2004 Nov; 66(2):133-8. PubMed ID: 15533580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical use of a new hypoglycemic agent: buformin].
    Leone S; Modicano V; Scapellato L
    Clin Ter; 1976 Sep; 78(6):527-35. PubMed ID: 1017159
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of IRI and some blood lipid indices after buformin administration].
    Quartarone M; Saitta A; Caruso G; Monacciani U; Perdichizzi G; Squadrito G
    Minerva Med; 1979 May; 70(22):1623-8. PubMed ID: 450301
    [No Abstract]   [Full Text] [Related]  

  • 9. [The potentials for the balneotherapy of obesity using arsenic-containing mineral water].
    Ivanov EM; Antoniuk MV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1998; (3):11-4. PubMed ID: 9771136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of diabetic fatty liver with Buformin].
    Möller E
    Med Klin; 1967 Dec; 62(48):1873-6. PubMed ID: 5591974
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of the transplacental blastomogenic effect of N-nitrosomethylurea in rats by buformin].
    Anisimov VN; Aleksandrov VA; Belous NM; Vasil'eva IA; Matson VB
    Biull Eksp Biol Med; 1980 Jul; 89(7):88-90. PubMed ID: 6996759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Joly JP: [Obesity and fast therapy. Immediate and long-term reducing]].
    Schrub JC; Hillemand B; Dubuisson M
    Sem Hop; 1971 Jan; 47(4):217-27. PubMed ID: 4322129
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of reactive hypoglycemia with buformin.
    Sekso M; Solter M; Zjacić V; Cabrijan T
    Am J Clin Nutr; 1975 Nov; 28(11):1271-6. PubMed ID: 1190104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies of the effect of N1-n-butylbiguanide hydrochloride (Buformin) and N1-n-butylbiguanide tosylate (Buformin retard)].
    Singer P; Thoelke H
    Z Gesamte Inn Med; 1973 Aug; 28(16):504-6. PubMed ID: 4767598
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dynamics of lipid and carbohydrate metabolism in various methods of treatment of obesity].
    Vasiukova EA; Olefirenko VT; Granovskaia-Tsvetkova AM; Vinogradova IM
    Ter Arkh; 1979; 51(12):97-9. PubMed ID: 538727
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diet with contrast and fat days in the balneotherapy of obesity].
    Kolominský J; Doberský P
    Fysiatr Revmatol Vestn; 1967 Jun; 45(3):136-44. PubMed ID: 5634211
    [No Abstract]   [Full Text] [Related]  

  • 17. [External respiratory function based on capnographic data during radon bath treatment of patients with exogenous-constitutional obesity].
    Amirov RZ; Mukharamova GA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1987; (3):55-7. PubMed ID: 3114951
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin].
    Dil'man VM; Bershteĭn LM; Tsyrlina EV; Bobrov IuF; Kovaleva IG
    Vopr Onkol; 1975; 21(11):33-9. PubMed ID: 1210118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The biguanides-insulin combination in the treatment of certain types of diabetes].
    Leng-Lévy J; Leng B; Aubertin J; Lacut JY; Le Gall F; Boget JC; Lenoir MP
    Bord Med; 1972 Dec; 5(19):2659-64. PubMed ID: 4659799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.